UPDATE : Monday, October 21, 2019
Hanmi, Enzychem challenge Amgen in neutropenia treatment
Hanmi Pharmaceutical and Enzychem Lifesciences are gearing up to fight agai...
by Jeong Sae-im  |  2019-04-09 12:15
Kolon confirms cancerous cell lines in Invossa
Kolon Life Science has confirmed cancerous cell lines in Invossa-K, a degen...
by Lee Han-soo  |  2019-04-09 11:16
Dong-A ST’s investigational drug posts positive study results
Dong-A ST’s hard work to develop an innovative medicine appears to be final...
by Jeong Sae-im  |  2019-04-08 16:00
Saxenda no silver bullet for weight loss, doctors warn
Obesity specializing physicians are warning against the growing popularity ...
by Kim Yun-mi  |  2019-04-05 16:21
ISU Abxis’ US partner to start P2b trials of hemophilia B treatment
ISU Abxis said Friday that Catalyst Biosciences, its U.S. partner, has begu...
by Lee Han-soo  |  2019-04-05 16:16
Gemvax & Kael’s wins nod for P3 trial of benign prostatic hyperplasia treatment
Gemvax & Kael said Friday that the Ministry of Food and Drug Safety has app...
by Lee Han-soo  |  2019-04-05 14:49
Handok, CMG apply for P1 trial for anticancer treatment candidate
Handok and CMG Pharmaceutical said they have applied to the Ministry of Foo...
by Lee Han-soo  |  2019-04-05 12:23
Court suspends ministry’s disciplinary action against Dong-A ST
The Seoul Administrative Court Wednesday suspended the Ministry of Health a...
by Lee Han-soo  |  2019-04-04 16:55
Corestem’s Lou Gehrig disease treatment becomes orphan drug in EU
Corestem said Wednesday that NeuroNata-R, its Lou Gehrig's disease ther...
by Lee Han-soo  |  2019-04-04 15:25
Genexine, NeoImmuneTech release 2 clinical trial results at AACR
Genexine and NeoImmuneTech said Thursday that they have presented two poste...
by Lee Han-soo  |  2019-04-04 14:16
GC, Clinigen K.K. ink licensing accord for Hunter syndrome drug
GC said Thursday that it has signed an exclusive licensing agreement to com...
by Lee Han-soo  |  2019-04-04 11:19
Fate of Kolon Life Science hangs on Invossa-K test results
The drug authorities will decide the level of a sanction against Kolon Life...
by Lee Hye-seon  |  2019-04-03 18:14
[Special] MSD Korea makes wrong excuse on external monitoring
After Korea Biomedical Review’s exclusive report revealed that MSD Korea co...
by Jeong Sae-im  |  2019-04-03 16:59
GC releases preclinical trial results for immunotherapy candidate at AACR
GC said Wednesday that it has presented the preclinical trial results of MG...
by Lee Han-soo  |  2019-04-03 14:18
Qurient displays immunotherapy candidate at AACR
Qurient said Wednesday that it held a poster session to present the preclin...
by Lee Han-soo  |  2019-04-03 14:18
Kang becomes new CEO of Abbvie Korea
Abbvie Korea said Monday that it has appointed Kang So-young as its new gen...
by Lee Han-soo  |  2019-04-03 10:50
Lilly’s migraine-preventing therapy becomes orphan drug here
The Ministry of Food and Drug Safety (MFDS) announced Monday that it has gi...
by Lee Han-soo  |  2019-04-02 16:09
‘Paternity testing’ would have prevented Invossa debacle
Kolon Life Science’s mislabeling one of the ingredients of Invossa-K, gene ...
by Jeong Sae-im  |  2019-04-02 15:27
[Special] MSD Korea asks monitoring agents to record talks ‘discreetly’
MSD Korea’s Self-Assurance program initially aimed to ensure legitimacy, tr...
by Jeong Sae-im  |  2019-04-02 14:45
Kolon apologizes for ‘mislabeled’ ingredient in Invossa
Kolon Life Science apologized Monday for “mislabeling” one of its key compo...
by Lee Han-soo  |  2019-04-01 17:35
Back to Top